VJOncology is committed to improving our service to you

ESMO WCGIC 2020 | Patient-derived orthotopic xenograft models of esophageal adenocarcinoma

VJOncology is committed to improving our service to you

Omkara Veeranki

Omkara Veeranki, MD, of the University of Texas MD Anderson Cancer Center, Houston, TX, discusses the development of patient-derived orthotopic xenograft mouse models of esophageal adenocarcinoma and their importance in treating gastrointestinal malignancies. Furthermore, Dr Veerkanki outlines how this model can be used for multimodality treatment analysis, including radiotherapy. This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).

Share this video  

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter